...
首页> 外文期刊>Journal of Clinical Immunology >Increased Serum Levels of Soluble CD30 in Patients with Common Variable Immunodeficiency and Its Clinical Implications
【24h】

Increased Serum Levels of Soluble CD30 in Patients with Common Variable Immunodeficiency and Its Clinical Implications

机译:常见可变免疫缺陷病患者血清可溶性CD30水平升高及其临床意义

获取原文
获取原文并翻译 | 示例

摘要

Common variable immunodeficiency (CVID) is a heterogeneous group of disorders, characterized by hypogammaglobulinemia and increased susceptibility to recurrent pyogenic infections, autoimmunity, and malignancies. Twenty-five cases with CVID (18 male and 7 female) and 25 healthy volunteers were investigate in this study. Soluble CD30 (sCD30) serum levels of the subjects were measured and compared. Serum levels of sCD30 in the patients with CVID were significantly increased in comparison with controls (36.93 ± 32.38 vs 5.27 ± 1.32 U/ml, P < 0.001). The group of patients with splenomegaly and reversed ratio of CD3+CD4+ T cells/CD3+CD8+ T cells had the highest serum levels of sCD30 (66.01 ± 43.34 U/ml) in comparison with other patients (P = 0.010). High levels of sCD30 in the CVID patients with splenomegaly and the presence of lymphoma in a patient with the highest level of sCD30 may suggest a soluble form of this marker as a prognostic tool in such diseases.
机译:常见可变免疫缺陷症(CVID)是一组异质性疾病,其特征为低球蛋白血症和对化脓性感染反复发作,自身免疫性和恶性肿瘤的敏感性增加。本研究调查了25例CVID病例(男18例,女7例)和25名健康志愿者。测量并比较受试者的可溶性CD30(sCD30)血清水平。与对照组相比,CVID患者的血清sCD30水平显着增加(36.93±32.38 vs 5.27±1.32 U / ml,P <0.001)。与其他患者相比,患有脾肿大且CD3 + CD4 + T细胞/ CD3 + CD8 + T细胞比率颠倒的患者组的sCD30血清水平最高(66.01±43.34 U / ml)(P = 0.010)。患有脾肿大的CVID患者中高水平的sCD30和高水平sCD30的患者中存在淋巴瘤可能表明该标志物的可溶形式可作为此类疾病的预后工具。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号